Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.980
+0.080 (1.63%)
Sep 28, 2026, 3:30 PM EDT - Market open
Champions Oncology Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
| 60.66 | 59.43 | 56.94 | 50.16 | 53.87 | 49.11 | |
Revenue Growth | 6.65% | 4.36% | 13.54% | -6.90% | 9.70% | 19.66% |
Cost of Revenue | 30.44 | 30.9 | 28.39 | 29.4 | 29.53 | 23.63 |
Gross Profit | 30.22 | 28.53 | 28.56 | 20.75 | 24.34 | 25.48 |
Selling, General & Admin | 21.81 | 20.47 | 16.88 | 18.13 | 17.24 | 15.5 |
Research & Development | 9.35 | 9.08 | 6.83 | 9.54 | 11.55 | 9.37 |
Operating Expenses | 31.15 | 29.55 | 23.71 | 27.68 | 28.79 | 24.87 |
Operating Income | -0.93 | -1.03 | 4.85 | -6.92 | -4.45 | 0.61 |
Interest Expense | - | - | - | -0.03 | - | - |
Interest & Investment Income | - | - | - | 0.09 | - | - |
Currency Exchange Gain (Loss) | - | - | - | -0.02 | -0.01 | -0.02 |
Other Non Operating Income (Expenses) | 0.13 | 0.21 | 0.07 | - | - | - |
EBT Excluding Unusual Items | -0.8 | -0.82 | 4.92 | -6.87 | -4.46 | 0.58 |
Gain (Loss) on Sale of Assets | -0.09 | -0.11 | -0.29 | -0.44 | - | - |
Asset Writedown | - | - | - | - | -0.81 | - |
Pretax Income | -0.89 | -0.93 | 4.63 | -7.31 | -5.27 | 0.58 |
Income Tax Expense | 0.24 | 0.25 | -0.08 | -0.03 | 0.07 | 0.04 |
Net Income | -1.14 | -1.18 | 4.7 | -7.28 | -5.34 | 0.55 |
Net Income to Common | -1.14 | -1.18 | 4.7 | -7.28 | -5.34 | 0.55 |
Net Income Growth | - | - | - | - | - | 51.38% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 13 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change | -2.42% | -3.04% | 5.31% | 0.04% | -4.37% | -2.84% |
EPS (Basic) | -0.08 | -0.08 | 0.34 | -0.54 | -0.39 | 0.04 |
EPS (Diluted) | -0.08 | -0.08 | 0.33 | -0.54 | -0.39 | 0.04 |
EPS Growth | - | - | - | - | - | 100.01% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Free Cash Flow | -6.14 | -5.04 | 7 | -6.97 | 1.1 | 4.11 |
Free Cash Flow Per Share | -0.44 | -0.36 | 0.49 | -0.52 | 0.08 | 0.29 |
Gross Margin | 49.82% | 48.00% | 50.15% | 41.38% | 45.18% | 51.88% |
Operating Margin | -1.54% | -1.73% | 8.51% | -13.80% | -8.26% | 1.24% |
Profit Margin | -1.87% | -1.98% | 8.25% | -14.51% | -9.90% | 1.12% |
Free Cash Flow Margin | -10.12% | -8.48% | 12.29% | -13.90% | 2.04% | 8.38% |
EBITDA | 0.4 | 0.35 | 6.49 | -5.05 | -2.83 | 2.23 |
EBITDA Margin | 0.66% | 0.59% | 11.39% | -10.08% | -5.26% | 4.55% |
D&A For EBITDA | 1.33 | 1.38 | 1.64 | 1.87 | 1.62 | 1.63 |
EBIT | -0.93 | -1.03 | 4.85 | -6.92 | -4.45 | 0.61 |
EBIT Margin | -1.54% | -1.73% | 8.51% | -13.80% | -8.26% | 1.24% |
Effective Tax Rate | - | - | - | - | - | 6.00% |